such as the EVO/EVO + Toric ICL. “FDA’s approval of STAAR’s Visian Toric ICL in the U.S. provides an exciting treatment option for myopic patients with astigmatism in search of visual freedom.

Nearly 100,000 of STAAR's Visian Toric ICL lenses have been successfully implanted in patients throughout the 60 markets where it is approved. The Company's CentraFLOW™, which simplifies ICL ...

--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ ... but not limited to FDA requirements regarding the Visian Toric ICL and/or actions related to the FDA Warning Letter and Form FDA-483s ...

STAAR Surgical Co. has received an “approvable ... Mr. Bailey noted that the recent marketing approval for the Visian Toric ICL (TICL) in South Korea and Canada and the approval of the ...

"The FDA's approval of STAAR's Visian Toric ICL provides an exciting treatment option for myopic patients with astigmatism in search of visual freedom. We are pleased to partner with Barnet ...

Co provided an update on the status of the co's submission to the FDA for approval of its Visian TICL, a toric implantable Collamer lens designed to treat both myopia and astigmatism. STAAR ...

In September, STAAR received FDA approval for its "Toric ICL" which corrects for astigmatism. Overall the combination of sales momentum and new products set a runway for growth going forward.

"The Visian ICL and Toric ICL V4c with STAAR's CentraFLOW technology utilizing the KS-AquaPORT' were launched in Europe in the fourth quarter of 2011. CentraFLOW eliminates the need for the ...

STAAR Surgical Company (NASDAQ ... used monthly disposable contact lenses and glasses. She received toric EVO ICL lenses to achieve Visual Freedom and break free from contact lenses and glasses.

Staar, based in Monrovia, CA, is seeking approval to use the Visian Toric ICL to treat myopia and astigmatism. The refractive, phakic implant is a variation of the company's Visian ICL ...

The big ticket item on the Staar Surgical horizon would be approval from the FDA for its toric ICL, which is expected some time early this year -- it is also seeking approval in Japan for the ...

David Bailey, STAAR’s president and chief executive officer, noted that the recent marketing approval for the Visian Toric ICL (TICL) in South Korea and Canada and the approval of the TICL and ...